Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma.

[1]  J. Mehnert,et al.  The Association of Radiation Therapy and Chemotherapy on Overall Survival in Merkel Cell Carcinoma: A Population-Based Analysis , 2021, Cureus.

[2]  N. Maloney,et al.  Prognostic value of lymphovascular invasion in early-stage Merkel cell carcinoma: a retrospective analysis in the National Cancer Database. , 2021, Journal of the American Academy of Dermatology.

[3]  O. Gjyshi,et al.  Payment Methodology for the Radiation Oncology Alternative Payment Model: Implications for Practices and Suggestions for Improvement. , 2021, JCO oncology practice.

[4]  M. Sabel,et al.  Immunotherapy for Merkel cell carcinoma , 2021, Journal of surgical oncology.

[5]  J. Liao,et al.  Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and Neck , 2020, Advances in Radiation Oncology.

[6]  N. Andruska,et al.  Palliative single‐fraction whole liver radiation therapy for diffuse liver metastases from metastatic Merkel cell carcinoma , 2020, The Journal of dermatology.

[7]  M. Lango,et al.  Effect of Sentinel Lymph Node Biopsy and LVI on Merkel Cell Carcinoma Prognosis and Treatment , 2020, The Laryngoscope.

[8]  M. Luu,et al.  Improved survival in women versus men with merkel cell carcinoma. , 2020, Journal of the American Academy of Dermatology.

[9]  C. Yashar,et al.  Radiation Oncology APM: an introduction and primer for the proposed rule for practices and providers. , 2020, Practical radiation oncology.

[10]  J. Taube,et al.  Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  V. Sondak,et al.  Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival? , 2020, Annals of Surgical Oncology.

[12]  J. Zhu,et al.  Medically inoperable Merkel cell carcinoma of the head and neck treated with stereotactic body radiation therapy: a case report. , 2020, Annals of palliative medicine.

[13]  T. Ohno,et al.  Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma , 2020, Cureus.

[14]  M. M. Qureshi,et al.  Identifying an Optimal Adjuvant Radiotherapy Dose for Extremity and Trunk Merkel Cell Carcinoma Following Resection: An Analysis of the National Cancer Database , 2017, JAMA dermatology.

[15]  Nicholas G Zaorsky,et al.  Hypofractionated radiation therapy for basal and squamous cell skin cancer: A meta-analysis. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  N. Giacalone,et al.  Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection , 2017, Head & neck.

[17]  G. Linette,et al.  Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. , 2016, The Lancet. Oncology.

[18]  J. Decaprio,et al.  Merkel Cell Carcinoma: A Population Analysis on Survival. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[19]  V. Sondak,et al.  Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma , 2016, Annals of Surgical Oncology.

[20]  A. Sober,et al.  Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System , 2016, Annals of Surgical Oncology.

[21]  Drew M. Pardoll,et al.  PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. , 2016, The New England journal of medicine.

[22]  J. Liao,et al.  Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma , 2015, Cancer medicine.

[23]  W. Kwan,et al.  Outcomes of Merkel Cell Carcinoma Treated with Radiotherapy without Radical Surgical Excision , 2014, Annals of Surgical Oncology.

[24]  E. M. Warton,et al.  Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma. , 2014, JAMA dermatology.

[25]  L. Misery,et al.  Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  D. Kraus,et al.  Five Hundred Patients With Merkel Cell Carcinoma Evaluated at a Single Institution , 2011, Annals of surgery.

[27]  P. Nghiem,et al.  Radiation monotherapy as regional treatment for lymph node‐positive Merkel cell carcinoma , 2010, Cancer.

[28]  S. Hewitt,et al.  Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin. , 2009, International journal of radiation oncology, biology, physics.

[29]  Arash Mostaghimi,et al.  Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. , 2008, Journal of the American Academy of Dermatology.

[30]  M. Weinstock,et al.  Adjuvant local irradiation for Merkel cell carcinoma. , 2006, Archives of dermatology.

[31]  V. Gebski,et al.  MERKEL CELL CARCINOMA: IMPROVED OUTCOME WITH ADJUVANT RADIOTHERAPY , 2005, ANZ journal of surgery.

[32]  D. Coit,et al.  Merkel cell carcinoma: prognosis and treatment of patients from a single institution. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  Danny Rischin,et al.  High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  C. Fournier,et al.  Radiotherapy alone for primary Merkel cell carcinoma. , 2003, Archives of dermatology.

[35]  L. Clegg,et al.  Epidemiology of primary Merkel cell carcinoma in the United States. , 2003, Journal of the American Academy of Dermatology.

[36]  C. Toker,et al.  Trabecular carcinoma of the skin. An ultrastructural study , 1978, Cancer.

[37]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[38]  C. Toker.  Trabecular carcinoma of the skin. , 1972, Archives of dermatology.